In the early stage of NAFLD, LSECs displayed increased PECAM-1, E-selectin and ICAM-1 expression (Figure 2B–D) without changes in mRNA expression of pro-inflammatory genes (Figure 3A–D) or prostanoid production (Figure 4A–D). This evidence concerns the gene PECAM1 and metabolic dysfunction-associated steatotic liver disease.